Treace Medical Concepts TMCI
NASDAQ TMCI
$4.53 -0.10 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) Net Margin Growth (3y) (2023 - 2026)

Analysis

Treace Medical Concepts (TMCI) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -641.00
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 420.00
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 484.00
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 459.00
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 941.00
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -1,024.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 574.00
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 300.00
10 Treace Medical Concepts 312.82 Mn 267.20 Mn 35.61 Mn -595.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -595.00
Mar 31, 2026 -645.00
Dec 31, 2025 -192.00
Sep 30, 2025 409.00
Jun 30, 2025 2,054.00
Mar 31, 2025 57.00
Dec 31, 2024 1,889.00
Sep 30, 2024 -443.00
Jun 30, 2024 -2,316.00
Mar 31, 2024 -2,284.00
Dec 31, 2023 -2,023.00
Sep 30, 2023 -2,331.00
Jun 30, 2023 -193.00
Mar 31, 2023 -1,651.00